Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

富维斯特朗 帕博西利布 癌症研究 乳腺癌 成纤维细胞生长因子受体 雌激素受体 癌症 ErbB公司 生物 MAPK/ERK通路 医学 成纤维细胞生长因子 转移性乳腺癌 内科学 信号转导 受体 遗传学
作者
Pingping Mao,Ofir Cohen,Kailey J. Kowalski,Justin G. Kusiel,Jorge E. Buendia-Buendia,Michael S. Cuoco,Pedro Exman,Seth A. Wander,Adrienne G. Waks,Utthara Nayar,Jon Chung,Samuel S. Freeman,Orit Rozenblatt–Rosen,Vincent A. Miller,Federica Piccioni,David E. Root,Aviv Regev,Eric P. Winer,Nancy U. Lin,Nikhil Wagle
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:26 (22): 5974-5989 被引量:136
标识
DOI:10.1158/1078-0432.ccr-19-3958
摘要

To identify clinically relevant mechanisms of resistance to ER-directed therapies in ER+ breast cancer.We conducted a genome-scale functional screen spanning 10,135 genes to investigate genes whose overexpression confer resistance to selective estrogen receptor degraders. In parallel, we performed whole-exome sequencing in paired pretreatment and postresistance biopsies from 60 patients with ER+ metastatic breast cancer who had developed resistance to ER-targeted therapy. Furthermore, we performed experiments to validate resistance genes/pathways and to identify drug combinations to overcome resistance.Pathway analysis of candidate resistance genes demonstrated that the FGFR, ERBB, insulin receptor, and MAPK pathways represented key modalities of resistance. The FGFR pathway was altered via FGFR1, FGFR2, or FGF3 amplifications or FGFR2 mutations in 24 (40%) of the postresistance biopsies. In 12 of the 24 postresistance tumors exhibiting FGFR/FGF alterations, these alterations were acquired or enriched under the selective pressure of ER-directed therapy. In vitro experiments in ER+ breast cancer cells confirmed that FGFR/FGF alterations led to fulvestrant resistance as well as cross-resistance to the CDK4/6 inhibitor palbociclib. RNA sequencing of resistant cell lines demonstrated that FGFR/FGF induced resistance through ER reprogramming and activation of the MAPK pathway. The resistance phenotypes were reversed by FGFR inhibitors, a MEK inhibitor, and/or a SHP2 inhibitor.Our results suggest that FGFR pathway is a distinct mechanism of acquired resistance to ER-directed therapy that can be overcome by FGFR and/or MAPK pathway inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
林3完成签到,获得积分10
1秒前
1秒前
1秒前
赘婿的应助被冥土追魂采纳,获得10
2秒前
2秒前
852的应助被归海天与采纳,获得10
2秒前
3秒前
mingyahaoa完成签到,获得积分0
3秒前
3秒前
小马过河发布了新的文献求助10
4秒前
丘比特的应助被zmrright采纳,获得10
4秒前
yuan完成签到,获得积分10
4秒前
5秒前
5秒前
急急急完成签到,获得积分20
5秒前
Akim的应助被CT采纳,获得10
6秒前
6秒前
6秒前
WY发布了新的文献求助10
6秒前
小盆友完成签到,获得积分10
7秒前
7秒前
研友_ndvmV8发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
飞行雪绒发布了新的文献求助10
8秒前
偏执苦楚发布了新的文献求助10
8秒前
ddiou发布了新的文献求助10
9秒前
Nole的应助被无心的画笔采纳,获得10
9秒前
9秒前
Gloria2026完成签到,获得积分10
9秒前
9秒前
CipherSage的应助被xh采纳,获得10
9秒前
冷酷的寒烟完成签到 ,获得积分10
10秒前
10秒前
充电宝的应助被依然小鬼采纳,获得10
11秒前
lingboxian完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047